CD8A and neoplasm: KDs could also modulate immune function as they were found to enhance the innate and adaptive immune responses against tumor cells, including cytolysis mediated by tumor-reactive CD8+ T cells [83], and to influence the activity of mammalian target of rapamycin (mTOR), which regulates the immune function [84].